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Introduction
Patients suffering from systemic sclerosis (SSc) have a
highly increased risk of developing pulmonary arterial
hypertension (PAH). An early detection of PAH is crucial
in order to halt the progress of disease. The assessment of
pulmonary vascular pressures currently lacks reliable
quantitative non-invasive measures.
Purpose
The aim of this study was therefore to use magnetic reso-
nance imaging (MRI) to explore the pulmonary blood
volume (PBV), the PBV variation (PBVV) over the cardiac
cycle, and the pulmonary blood density (PBD) as possible
measures of PAH in newly diagnosed SSc.
Methods
Thirty-nine SSc patients (25 women and 14 men, 31-81
years, mean 58 years) and healthy individuals (five
women and 13 men, 20-46 years, mean 27) underwent
cardiac MRI. PBV was calculated as the product of cardiac
output determined by velocity encoded MRI, and the pul-
monary transit time (PTT) determined as the time for a 2
ml intravenously administered contrast bolus to pass
from the pulmonary trunk to the left atrium. The lung vol-
ume was determined by planimetry using transversal MR
images covering the lungs. The PBD was defined as the
PBV divided by the lung volume. Also, the blood flow in
the pulmonary artery and the pulmonary veins was meas-
ured using velocity encoded MRI. The PBVV was calcu-
lated by integration of the difference in arterial and
venous pulmonary flow over the cardiac. PBV and PBD
were measured in eight healthy individuals (two women
and six men, 20-46 years, mean 31 years). In 10 healthy
volunteers (three women and 7 men, 21-30 years, mean
24 years), the PBVV was assessed. The SSc patients were
then compared to the healthy subjects considering PBV
and PBD, and PBVV, respectively.
Results
Stroke volume and PBV in 36 SSc patients and eight
healthy subjects were respectively (mean ± SD) 77 ± 20 ml
vs 95 ± 10 ml, 467 ± 111 ml vs 575 ± 149 ml. PBD was 17
± 5% vs 20 ± 4%. PBVV in 32 SSc patients and 10 healthy
individuals were respectively 31 ± 9 ml vs 45 ± 14 ml.
Conclusion
This study is the first to show the feasibility to assess the
PBD using MRI. Data shows no difference between newly
diagnosed SSc patients and healthy individuals consider-
ing PBD, nor PBVV. The PBD may be a useful prognostic
non-invasive measure of PAH and cardiac failure. There-
fore, further studies are needed to reveal the importance of
the PBD in these contexts.
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